TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
企業コードTXMD
会社名TherapeuticsMD Inc
上場日Jan 31, 2001
最高経営責任者「CEO」Mr. Marlan D. Walker, J.D.
従業員数1
証券種類Ordinary Share
決算期末Jan 31
本社所在地951 Yamato Road, Suite 220
都市BOCA RATON
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号33431
電話番号15619611900
ウェブサイトhttps://www.therapeuticsmd.com/
企業コードTXMD
上場日Jan 31, 2001
最高経営責任者「CEO」Mr. Marlan D. Walker, J.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし